B. Fiquet

899 total citations
18 papers, 379 citations indexed

About

B. Fiquet is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B. Fiquet has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B. Fiquet's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Blood Pressure and Hypertension Studies (4 papers). B. Fiquet is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Blood Pressure and Hypertension Studies (4 papers). B. Fiquet collaborates with scholars based in France, Slovakia and Italy. B. Fiquet's co-authors include Emmanuel Letavernier, Laurence Amar, Franck Zinzindohoué, Séverine Peyrard, S. Dejager, Stéphane Quéré, Laurence Mier, Georges Saumon, Kamel Djedaïni and F Coste and has published in prestigious journals such as CHEST Journal, Journal of Hypertension and Diabetes Research and Clinical Practice.

In The Last Decade

B. Fiquet

16 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Fiquet France 8 258 188 71 54 48 18 379
A Harari France 8 163 0.6× 104 0.6× 60 0.8× 104 1.9× 33 0.7× 20 385
Sofia Syed United States 3 391 1.5× 58 0.3× 49 0.7× 120 2.2× 19 0.4× 4 544
Angela Price United States 9 116 0.4× 161 0.9× 33 0.5× 207 3.8× 46 1.0× 15 430
Nora Luethi Australia 12 112 0.4× 67 0.4× 40 0.6× 52 1.0× 133 2.8× 29 444
Roland Gaertner Germany 6 81 0.3× 30 0.2× 74 1.0× 22 0.4× 37 0.8× 9 396
Min‐Hsiang Chuang Taiwan 12 79 0.3× 47 0.3× 64 0.9× 22 0.4× 49 1.0× 70 429
Syed Haris Ahmed United Kingdom 9 101 0.4× 63 0.3× 41 0.6× 11 0.2× 32 0.7× 13 229
Myriam Lessard Canada 5 127 0.5× 58 0.3× 11 0.2× 187 3.5× 42 0.9× 7 334
L. Álvarez-Sala Spain 11 102 0.4× 128 0.7× 66 0.9× 200 3.7× 4 0.1× 24 373
Jonathan Shaw Australia 6 82 0.3× 51 0.3× 18 0.3× 81 1.5× 26 0.5× 6 306

Countries citing papers authored by B. Fiquet

Since Specialization
Citations

This map shows the geographic impact of B. Fiquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Fiquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Fiquet more than expected).

Fields of papers citing papers by B. Fiquet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Fiquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Fiquet. The network helps show where B. Fiquet may publish in the future.

Co-authorship network of co-authors of B. Fiquet

This figure shows the co-authorship network connecting the top 25 collaborators of B. Fiquet. A scholar is included among the top collaborators of B. Fiquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Fiquet. B. Fiquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Châtellier, Gilles, B. Fiquet, Antoine Chédid, et al.. (2018). FEASIBILITY OF ESTIMATING FIBROMUSCULAR DYSPLASIA PREVALENCE USING HEALTH ADMINISTRATIVE DATABASE. Journal of Hypertension. 36(Supplement 1). e39–e39. 1 indexed citations
2.
3.
Gautier, Jean–François, O. Vérier‐Mine, Paul Valensi, et al.. (2016). Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?. Diabetes Research and Clinical Practice. 116. 26–28. 3 indexed citations
4.
Joly, Dominique, Gabriel Choukroun, Christian Combe, et al.. (2015). Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: A prospective observational study. Diabetes Research and Clinical Practice. 108(1). 120–127. 6 indexed citations
5.
Auzan, Colette, B. Fiquet, Arnaud Garnier, et al.. (2015). 6C.01. Journal of Hypertension. 33(Supplement 1). e79–e79. 4 indexed citations
6.
Dejager, S., Alfred Penfornis, B. Fiquet, & J F Blicklé. (2015). Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study. Diabetes Metabolic Syndrome and Obesity. 8. 303–303. 13 indexed citations
7.
Dejager, S., et al.. (2015). Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study. Vascular Health and Risk Management. 11. 361–361. 38 indexed citations
8.
9.
Dejager, S., Alfred Penfornis, Jean‐Frédéric Blickle, B. Fiquet, & Stéphane Quéré. (2014). How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study. Vascular Health and Risk Management. 10. 341–341. 27 indexed citations
10.
Sosner, P., et al.. (2013). How are physicians prescribing the direct renin inhibitor aliskiren in the management of essential hypertension? A French observational study. Journal of Hypertension. 31(7). 1491–1496. 1 indexed citations
12.
Letavernier, Emmanuel, et al.. (2009). Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Journal of Hypertension. 27(3). 657–658. 98 indexed citations
13.
Amar, Laurence, et al.. (2009). La dysplasie fibromusculaire des artères rénales. Archives des Maladies du Coeur et des Vaisseaux - Pratique. 2009(181). 12–17. 1 indexed citations
14.
Letavernier, Emmanuel, et al.. (2008). Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. Journal of Hypertension. 26(9). 1816–1823. 101 indexed citations
15.
Baguet, J.-P., et al.. (2007). Attitudes to and application of the concept of overall cardiovascular risk: comparison of male and female primary care providers. Journal of Human Hypertension. 21(5). 359–365. 1 indexed citations
16.
Beaurain, Geneviève, Flavie Mathieu, B. Fiquet, et al.. (2006). Dehydrated hereditary stomatocytosis mimicking familial hyperkalaemic hypertension: clinical and genetic investigation. European Journal Of Haematology. 78(3). 253–259. 7 indexed citations
17.
Girerd, Xavier, Thierry Denolle, B. Fiquet, et al.. (2004). Automated office and home phone-transmitted blood pressure recordings in uncontrolled hypertension treated with valsartan and hydrochlorothiazide. Blood Pressure. 13(2). 18–24. 4 indexed citations
18.
Bourdellés, Geneviève Le, Laurence Mier, B. Fiquet, et al.. (1996). Comparison of the Effects of Heat and Moisture Exchangers and Heated Humidifiers on Ventilation and Gas Exchange During Weaning Trials From Mechanical Ventilation. CHEST Journal. 110(5). 1294–1298. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026